Results 231 to 240 of about 4,968,206 (256)

The Measurement Properties and Applications of WHODAS 2.0 in Multiple Sclerosis: A Systematic Review. [PDF]

Med Sci (Basel)
Rizzo A, Maggio MG, Calderone A, Impellizzeri F, Pistorino G, Pitrone C, Sitibondo A, Meus F, Mazziotti R, Migliorini R, Burzomati D, Calabrò RS.   +11 more
europepmc   +1 more source

Selenium Nanoparticles Selectively Target KRAS G13D to Inhibit Colorectal Cancer

Advanced Science, EarlyView.
The mechanisms of SeNPs therapy in cancer treatment, encompass three parallel actions: (1) seleno‐amino acids, key metabolites, upregulate GPX2 expression, thereby inhibiting tumor metastasis via the GPX2‐HIF1α‐VEGF signaling pathway; (2) selenite (SeO32−), an inorganic metabolite, forms hydrogen bonds with amino acid residues 13–17 of the KRAS G13D ...
Xiaoting Liu, Chong Wu, Shiyao Song, Li Ma, Shaoqing Huang, Yuting He, Qinghai Li, Yanzhou Chang, Dan Jiang, Yong Mei, Junchao Cai, Zhenshuang Du, Tianfeng Chen, Weiling He   +13 more
wiley   +1 more source

Targeting progressive multiple sclerosis: Toward mechanism-informed precision medicine. [PDF]

J Intern Med
Piehl F, Castelo-Branco G, Jagodic M, Olsson T.   +3 more
europepmc   +1 more source

Investigating the treatment of vascular risk with simvastatin in secondary progressive multiple sclerosis: analysis from the MS-STAT2 randomized controlled trial. [PDF]

Brain Commun
Williams T, Magill N, John NA, Bianchi A, Blackstone J, Braisher M, De Angelis F, Calvi A, Apap Mangion S, Wade C, Yiannakas MC, Stutters J, Ricciardi A, Prados Carrasco F, MacManus D, Wheeler-Kingshott CAMG, Barkhof F, Ciccarelli O, Chataway J, the MS-STAT2 investigators, the MS-STAT2 investigators .   +20 more
europepmc   +1 more source

Efficacy and safety of mesenchymal stem cell transplantation for progressive multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials with clinical implications for patient stratification and treatment optimization. [PDF]

Front Immunol
Guo H, Zeng L, Sun L.
europepmc   +1 more source

MRI Correlates of Depression and Anxiety in Multiple Sclerosis. [PDF]

Diseases
Pascu LS, Mitincu-Caramfil SD, Bradeanu AV, Iacob A, Lungu M, Marinescu I, Drima EP.   +6 more
europepmc   +1 more source

Challenges and Innovation for Diagnosing and Treatment of Secondary Progressive Multiple Sclerosis. [PDF]

Int J Mol Sci
Uawithya E, Mytych JS, Muwenda I, Reidy M, Khan M, Mao-Draayer Y.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

Brain, 2023
Richard Macdonell, Yara Dadalti Fragoso, Angel Perez-Sempere   +2 more
exaly  

Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis: Multicenter study in Argentina

Multiple Sclerosis Journal, 2021
Edgar Carnero Contentti, Ricardo Alonso, Edgardo Cristiano   +2 more
exaly